2013 ACBD Publications

Book Chapters

Andrews, R.K., Berndt, M.C., 2013, Mocarhagin, in Handbook of proteolytic enzymes, eds Neil D Rawlings and Guy S Salvesen, Elsevier, Oxford UK, pp. 1073-1075.

Andrews, R.K., Berndt, M.C., 2013, The GPIb-IX-V Complex, in Platelets, eds Alan D Michelson, Elsevier, UK, pp. 195-213.

Haenebalcke, L., Haigh, J., 2013, Cre/loxP - Transgenics, in Brenner's Encyclopedia of Genetics, eds Stanley Maloy and Kelly Hughes, Academic Press, San Diego, pp. 212-217.

Nesbitt, W.S., Tovar-Lopez, F.J., Westein, E., Harper, I.S., Jackson, S., 2013, A multimode-TIRFM and microfluidic technique to examine platelet adhesion dynamics, in Adhesion Protein Protocols, eds Amanda S. Coutts, Humana Press, USA, pp. 39-58.

Opat, S., Butler, J., Malan, E., Duncan, E.M., Tran, H.A., 2013, Factor XIII assays, in Haemostasis: Methods and Protocols, eds Paul Monagle, Humana Press, United States, pp. 171-180.

Ruggeri, Z.M., Jackson, S., 2013, Platelet thrombus formation in flowing blood, in Platelets, eds Alan D Michelson, Academia Press, San Diego, CA, United States, pp. 399-423.

Conference Publication

Combariza, M.E., Yu, X., Tovar-Lopezy, F., Nesbitt, W.S., Mitchell, A., 2013, Modeling of dynamic platelet aggregation in response to shear rate micro-gradients in a microfluidics device, Proceedings of the Biosignals and Biorobotics Conference (BRC), 2013 ISSNIP, 18-20 February 2013, IEEE Xplore, USA, pp. 286-290.

Journal Articles

Andrews, R.K., Berndt, M.C., 2013, Bernard-Soulier syndrome: an update, Seminars In Thrombosis And Hemostasis [P], vol 39, issue 6, Thieme Medical Publishers, United States, pp. 656-662.

Arthur, J.F., Shen, Y., Chen, Y., Qiao, J.L., Ni, R., Lu, Y., Andrews, R.K., Gardiner, E.E., Cheng, J., 2013, Exacerbation of glycoprotein VI-dependent platelet responses in a rhesus monkey model of type 1 diabetes, Journal of Diabetes Research [P], vol 2013, issue Art. ID: 370212, Hindawi Publishing Corporation, United States, pp. 1-9.

Banerjee, A., Vasanthakumar, A., Grigoriadis, G., 2013, Modulating T regulatory cells in cancer: how close are we?, Immunology And Cell Biology [P], vol 91, issue 5, Nature Publishing Group, United Kingdom, pp. 340-349.

Bark Jr., D.L., Ku, D., 2013, Platelet transport rates and binding kinetics at high shear over a thrombus, Biophysical Journal [P], vol 105, issue 2, Cell Press, United States, pp. 502-511.

Berndt, M.C., Andrews, R.K., 2013, Platelet hem-immunoreceptor tyrosine-based activation motif receptors: at least one required, Arteriosclerosis Thrombosis And Vascular Biology [P], vol 33, issue 5, Lippincott Williams & Wilkins, United States, pp. 884-885.

Bishton, M.J., Gardiner, E.E., Harrison, S., Prince, H.M., Johnstone, R.W., 2013, Histone deacetylase inhibitors reduce glycoprotein VI expression and platelet responses to collagen related peptide, Thrombosis Research [P], vol 131, issue 6, Pergamon, United Kingdom, pp. 514-520.

Bishton, M.J., Spencer, A., Dickinson, M.J., Ritchie, D., 2013, A single-arm, phase II study of the anti-Blys monoclonal antibody belimumab in symptomatic Waldenstrom macroglobulinemia, Clinical Lymphoma, Myeloma & Leukemia [P], vol 13, issue 5, Elsevier Inc, USA, pp. 575-578.

Brown, F., Scott, N., Rank, G., Collinge, J.E., Vadolas, J., Vickaryous, N., Whitelaw, N.C., Whitelaw, E., Kile, B., Jane, S.M., Curtis, D.J., 2013, ENU mutagenesis identifies the first mouse mutants reproducing human beta-thalassemia at the genomic level, Blood Cells Molecules And Diseases [P], vol 50, issue 2, Academic Press, United States, pp. 86-92.

Buchanan, C.M., Dickson, J.M., Lee, W., Guthridge, M.A., Kendall, J.D., Shepherd, P.R., 2013, Oncogenic mutations of p110alpha isoform of PI 3-kinase upregulate its protein kinase activity, PLoS ONE [P], vol 8, issue 8 (Art. ID: e71337), Public Library of Science, United States, pp. 1-8.

Cangkrama, M., Ting, S.B.N., Darido, C., 2013, Stem cells behind the  barrier, International Journal of Molecular Sciences [P], vol 14, issue  7, M D P I AG, Switzerland, pp. 13670-13686.

Cellot, S., Hope, K., Chagraoui, J., Sauvageau, M., Deneault, E., MacRae, T., Mayotte, N., Wilhelm, B.T., Landry, J.R., Ting, S.B.N., Krosl, J., Humphries, K., Thompson, A., Sauvageau, G., 2013, RNAi screen identifies Jarid1b as a major regulator of mouse HSC activity, Blood [P], vol 122, issue 9, American Society of Hematology, United States, pp. 1545-1555.

Chan, W., Spencer, F., Lee, A., Chunilal, S., Douketis, J., Rodger, M., Ginsberg, J.S., 2013, Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging, Canadian Medical Association Journal [P], vol 185, issue 4, Canadian Medical Association, Canada, pp. E194-E200.

Chieng, R., Coutsouvelis, J., Poole, S.G., Dooley, M.J., Booth, D.L., Wei, A., 2013, Improving the transition of highly complex patients into the community: Impact of a pharmacist in an allogeneic stem cell transplant (SCT) outpatient clinic, Supportive Care In Cancer [P], vol 21, issue 12, Springer, Heidelberg Germany, pp. 3491-3495.

Cops, E., Sashindranath, M., Daglas, M., Short, K.M., Pereira, C.d.F., Pang, T., Lijnen, R., Smyth, I.M., Hannan, A.J., Samson, A.L., Medcalf, R.L., 2013, Tissue-type plasminogen activator is an extracellular mediator of Purkinje cell damage and altered gait, Experimental Neurology [P], vol 249C, Academic Press, United States, pp. 8-19.

Costa, M., Sourris, K., Lim, S.M., Yu, Q.C., Hirst, C.E., Parkington, H.C., Jameson, V.J., Dear, A.E., Liu, H.B., Micallef, S.J., Koutsis, K., Elefanty, A.G., Stanley, E., 2013, Derivation of endothelial cells from human embryonic stem cells in fully defined medium enables identification of lysophosphatidic acid and platelet activating factor as regulators of eNOS localization, Stem Cell Research [P], vol 10, issue 1, Elsevier BV, Netherlands, pp. 103-117.

Coutsouvelis, J., Wiseman, M., Hui, L., Poole, S.G., Dooley, M.J., Patil, S., Avery, S., Wei, A., Spencer, A., 2013, Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndrome, British Journal Of Clinical Pharmacology [P], vol 75, issue 2, Wiley-Blackwell Publishing Ltd, United Kingdom, pp. 550-553.

Davis, A., Walsh, M.E., McCarthy, P., Brown, G., Roberts, S., Tran, H.A., Street, A., Fong, C.Y., Kemp, W.W., 2013, Tranexamic acid without prophylactic factor replacement for prevention of bleeding in hereditary bleeding disorder patients undergoing endoscopy: a pilot study, Haemophilia [P], vol 19, issue 4, Wiley-Blackwell Publishing Ltd, United Kingdom, pp. 583-589.

Diakiw, S.M., Perugini, M., Kok, C.H., Engler, G., Cummings, N.J., To, L., Wei, A., Lewis, I.D., Brown, A.L., D'Andrea, R.J., 2013, Methylation of KLF5 contributes to reduced expression in acute myeloid leukaemia and is associated with poor overall survival, British Journal Of Haematology [P], vol 161, issue 6, Wiley-Blackwell Publishing Ltd, United Kingdom, pp. 884-888.

Engel, M., Sidwell, T., Vasanthakumar, A., Grigoriadis, G., Banerjee, A., 2013, Thymic regulatory T cell development: role of signalling pathways and transcription factors, Clinical & Developmental Immunology [P], vol 2013, issue Art # e617585, Hindawi Publishing Corporation, United States, pp. 1-9.

Estcourt, L.J., Heddie, N., Kaufman, R., McCullough, J., Murphy, M.F.G., Slichter, S., Wood, E.M., Stanworth, S., 2013, The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions, Transfusion [P], vol 53, issue 7, Wiley-Blackwell Publishing, Inc., United States, pp. 1531-1543.

Fong, C.Y., Grigoriadis, G., Hocking, J., Coutsouvelis, J., Muirhead, J.L., Campbell, P., Paul, E., Walker, P.A., Avery, S., Patil, S., Spencer, A., Schwarer, A., Wei, A., 2013, Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse, Leukemia & Lymphoma [P], vol 54, issue 2, Informa Healthcare, United Kingdom, pp. 336-341.

Gardiner, E.E., Andrews, R.K., 2013, Platelets: Envoys at the infection frontline, Journal Of Infectious Diseases [P], vol 208, issue 6, Oxford University Press, Cary, NC 27513 United States, pp. 871-873.

Ghahremani MF, Goossens S, Haigh, J.J., 2013, The p53 family and VEGF  regulation: "it's complicated", Cell Cycle [P], vol 12, issue 9, Landes  Bioscience, Austin, TX 78701 United States, pp. 1331-1332.

Ghasemzadeh, M., Hosseini, E., 2013, Platelet-leukocyte crosstalk: Linking proinflammatory responses to procoagulant state, Thrombosis Research [P], vol 131, issue 3, Pergamon, United Kingdom, pp. 191-197.

Ghasemzadeh, M., Kaplan, Z., Alwis, I., Schoenwaelder, S.M., Ashworth, K.J., Westein, E., Hosseini, E., Salem, H.H., Slattery, R.M., McColl, S.R., Hickey, M.J., ruggeri, Z.M., Yuan, Y., Jackson, S., 2013, The CXCR1/2 ligand NAP-2 promotes directed intravascular leukocyte migration through platelet thrombi, Blood [P], vol 121, issue 22, American Society of Hematology, United States, pp. 4555-4566.

Green, B.D., Jabbour, A.M., Sandow, J.J., Riffkin, C.D., Masouras, D., Daunt, C.P., Salmanidis, M., Brumatti, G., Hemmings, B., Guthridge, M.A., Pearson, R.B., Ekert, P.G., 2013, Akt1 is the principal Akt isoform regulating apoptosis in limiting cytokine concentrations, Cell Death and Differentiation [P], vol 20, issue 10, Nature Publishing Group, United Kingdom, pp. 1341-1349.

Gregory, G., Arumugaswamy, A., Leung, T., Chan, K., Abikhair, M., Tam, C., Bajel, A., Cher, L., Grigg, A., Ritchie, D., Opat, S., 2013, Rituximab is associated with improved survival for aggressive B cell CNS lymphoma, Neuro-Oncology [P], vol 15, issue 8, Oxford University Press, United States, pp. 1068-1073.

Haenebalcke, L., Goossens, S., Naessens, M., Kruse, N., Ghahremani, M.F., Bartunkova, S., Haigh, K., Pieters, T., Dierickx, P., Drogat, B., Nyabi, O., Wirth, D., Haigh, J.J., 2013, Efficient ROSA26-based conditional and/or inducible transgenesis using RMCE-compatible F1 hybrid mouse embryonic stem cells, Stem Cell Reviews [P], vol 9, issue 6, Humana Press, Inc., United States, pp. 774-785.

Hapgood, G., Butler, J., Malan, E., Chunilal, S., Tran, H.A., 2013, The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samples, Thrombosis and Haemostasis [P], vol 110, issue 2, Schattauer GmbH, Germany, pp. 308-315.

Haslinger, P., Haidar, S., Sonderegger, S.E., Otten, J.V., Pollheimer, J., Whitley, G., Knofler, M., 2013, AKT Isoforms 1 and 3 regulate basal and epidermal growth factor-stimulated SGHPL-5 trophoblast cell migration in humans, Biology Of Reproduction [P], vol 88, issue 3, Society for the Study of Reproduction, United States, pp. 1-11.

Herold, M., Rohrbeck, L., Lang, M., Grumont, R.J., Gerondakis, S.D., Tai, L., Bouillet, P., Kaufmann, T., Strasser, A., 2013, Foxo-mediated Bim transcription is dispensable for the apoptosis of hematopoietic cells that is mediated by this BH3-only protein, Embo Reports [P], vol 14, issue 11, Wiley-Blackwell Publishing Ltd, United Kingdom, pp. 992-998.

Hobson, S.R., Lim, R.S.W., Gardiner, E.E., Alers, N.O., Wallace, E.M., 2013, Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): Study protocol, BMJ Open [E], vol 3, issue 9, BMJ Publishing Group, England, pp. e003788-e003789.

Huard, C.C., Tremblay, C., Helsper, K., Delisle, M., Schindler, D., Levesque, G., Carreau, M., 2013, Fanconi anemia proteins interact with CtBP1 and modulate the expression of the Wnt antagonist Dickkopf-1, Blood [P], vol 121, issue 10, American Society of Hematology, United States, pp. 1729-1739.

Jaworski, C., Looi, J., Martin, J.J., Bergin, P., Hare, J., Kaye,  D.M., Wei, A., Taylor, A.J., 2013, Cardiac Imaging in FIP1L1-PDGFRA,  Journal of the American College of Cardiology [P], vol 62, issue 14,  Elsevier Inc., San Diego, CA 92122 United States, p. 1304.

Kantarjian, H.M., Martinelli, G., Jabbour, E., Quintas-Cardama, A., Ando, K., Bay, J., Wei, A., Gropper, S., Papayannidis, C., owen, K., Pike, L., Schmitt, N., Stockman, P., Giagounidis, A., 2013, Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia, Cancer [P], vol 119, issue 14, John Wiley & Sons, Inc., United States, pp. 2611-2619.

Krishnan, T., Winship, A., Sonderegger, S.E., Menkhorst, E., Horne, A.W., Brown, J., Zhang, J., Nicola, N.A., Tong, S., Dimitriadis, E., 2013, The role of leukemia inhibitory factor in tubal ectopic pregnancy, Placenta [P], vol 34, issue 11, Elsevier Ltd, United Kingdom, pp. 1014-1019.

Krishna, S.M., Dear, A.E., Craig, J., Norman, P., Golledge, J., 2013, The potential role of homocysteine mediated DNA methylation and associated epigenetic changes in abdominal aortic aneurysm formation, Atherosclerosis [P], vol 228, issue 2, Elsevier Ireland Ltd, Ireland, pp. 295-305.

Kruss, S., Erpenbeck, L., Amschler, K., Mundinger, T., Boehm, H., Helms, H., Friede, T., Andrews, R.K., Schon, M., Spatz, J., 2013, Adhesion maturation of neutrophils on nanoscopically presented platelet glycoprotein ibalpha, ACS Nano [P], vol 7, issue 11, American Chemical Society, United States, pp. 9984-9996.

Lee, D., Kalff, A., Low, M., Gangatharan, S., Ho, P., Bajel, A., Ritchie, D., Grigg, A., Spencer, A., 2013, Central nervous system multiple myeloma - potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains, British Journal Of Haematology [P], vol 162, issue 3, Wiley-Blackwell Publishing Ltd, UK, pp. 371-375.

Lee, H., Hamilton, J.R., 2013, The PAR1 antagonist, SCH79797, alters platelet morphology and function independently of PARs, Thrombosis and Haemostasis [P], vol 109, issue 1, Schattauer GmbH, Germany, pp. 164-167.

Leow, C., Gerondakis, S.D., Spencer, A., 2013, MEK inhibitors as a chemotherapeutic intervention in multiple myeloma, Blood Cancer Journal [E], vol 3, issue Art. ID: e105, Nature Publishing Group, United Kingdom, pp. 1-8.

Ling, V., Burnett, A., Bradstock, K.F., Seymour, J., Hills, R.K., Wei, A., 2013, Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (HiDAC) based induction chemotherapy, British Journal Of Haematology [P], vol 160, issue 6, Wiley-Blackwell Publishing Ltd, United Kingdom, pp. 861-863.

Li, S., Haigh, K., Haigh, J.J., Vasudevan, A., 2013, Endothelial VEGF sculpts cortical cytoarchitecture, Journal Of Neuroscience [P], vol 33, issue 37, Society for Neuroscience, United States, pp. 14809-14815.

Lonic, A., Powell, J.A., Kong, Y., Thomas, D., Hollen, J., Truong, N., Parker, M.W., Guthridge, M.A., 2013, Phosphorylation of serine 779 in fibroblast growth factor receptor 1 and 2 by protein kinase C(epsilon) regulates Ras/mitogen-activated protein kinase signaling and neuronal differentiation, Journal Of Biological Chemistry [P], vol 288, issue 21, American Society for Biochemistry and Molecular Biology, Inc., United States, pp. 14874-14885.

Low, M., Lee, D., Coutsouvelis, J., Patil, S., Opat, S., Walker, P.A., Schwarer, A., Salem, H.H., Avery, S., Spencer, A., Wei, A., 2013, High-dose cytarabine (24g/m2) in combination with idarubicin (HiDAC-3) results in high first-cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia, Internal Medicine Journal [P], vol 43, issue 3, Wiley-Blackwell Publishing Asia, Australia, pp. 294-297.

Matthews, J.M., Lester, K., Joseph, S., Curtis, D.J., 2013, LIM-domain-only proteins in cancer, Nature Reviews Cancer [P], vol 13, issue 2, Nature Publishing Group, United Kingdom, pp. 111-122.

McCormack, M.P., Shields, B.J., Jackson, J., Nasa, C., Shi, W.,  Slater, N.J., Tremblay, C., Rabbitts, T.H., Curtis, D.J., 2013,  Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor  ALL, Blood [P], vol 122, issue 12, American Society of Hematology,  United States, pp. 2093-2103.

McFadyen, J.D., Jackson, S., 2013, Differentiating haemostasis from thrombosis for therapeutic benefit, Thrombosis and Haemostasis [P], vol 110, issue 5, Schattauer GmbH, Germany, pp. 859-867.

Mesa, R.A., Gotlib, J., Gupta, V., Catalano, J., Deininger, M., Shields, A., Miller, C., Silver, R., Talpaz, M., Winton, E.F., Harvey, J.H., Hare, T., Erickson-Viitanen, S., Sun, W., Sandor, V., Levy, R.S., Kantarjian, H.M., Verstovsek, S., 2013, Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial, Journal of Clinical Oncology [P], vol 31, issue 10, merican Society of Clinical Oncology, United States, pp. 1285-1292.

Mithraprabhu, S., Khong, T.T.F., Jones, S., Spencer, A., 2013, Histone deacetylase (HDAC) inhibitors as single agents induce multiple myeloma cell death principally through the inhibition of class I HDAC, British Journal Of Haematology [P], vol 162, issue 4, Wiley-Blackwell Publishing Ltd, United Kingdom, pp. 559-562.

Niego, B., Medcalf, R.L., 2013, Improved method for the preparation of a human cell-based, contact model of the blood-brain barrier, Journal of Visualized Experiments [E], vol 81, issue Art ID: e50934, Journal of Visualized Experiments, United States, p. 1.

Northcott, M.J., Ong, W.L., Walsh, M., McCarthy, P., Belleli, D., Tran, H.A., Street, A.M., Kemp, W., Davis, A., 2013, Prevalence of transfusion-acquired hepatitis C in an Australian bleeding disorders population, Haemophilia [P], vol 19, issue 6, Wiley-Blackwell Publishing Ltd, United Kingdom, pp. 847-852.

Perugini, M., Iarossi, D., Kok, C., Cummings, N.J., Diakiw, S.M., Brown, A.L., Danner, S., Bardy, P., To, L.B., Wei, A., Lewis, I.D., Andrea, R., 2013, GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations, Leukemia [P], vol 27, issue 7, Nature Publishing Group, United Kingdom, pp. 1588-1592.

Qiao, J.L., Schoenwaelder, S.M., Mason, K.D., Tran, H.A., Davis, A., Kaplan, Z., Jackson, S., Kile, B., Andrews, R.K., roberts, a.W., Gardiner, E.E., 2013, Low adhesion receptor levels on circulating platelets in patients with lymphoproliferative diseases before receiving Navitoclax (ABT-263), Blood [P], vol 121, issue 8, American Society of Hematology, United States, pp. 1479-1481.

Saw, J.M.Y., Curtis, D.J., Hussey, D.J., Dobrovic, A., Aplan, P.D., Slape, C.I., 2013, The fusion partner specifies the oncogenic potential of NUP98 fusion proteins, Leukemia Research [P], vol 37, issue 12, Pergamon, United Kingdom, pp. 1668-1673.

Schuliga, M., Langenbach, S.Y., Xia, Y., Qin, C., Mok, J., Harris, T., Mackay, G., Medcalf, R.L., Stewart, A.G., 2013, Plasminogen-stimulated inflammatory cytokine production by airway smooth muscle cells is regulated by annexin A2, American Journal Of Respiratory Cell And Molecular Biology [P], vol 49, issue 5, American Thoracic Society, United States, pp. 751-758.

Shortt, J., Oh, D.H., Opat, S., 2013, ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura, New England Journal Of Medicine [P], vol 368, issue 1, Massachusetts Medical Society, Boston, MA 02115 United States, pp. 90-92.

Sleebs, B., Kersten, W.J.A., Kulasegaram, S., Nikolakopoulos, G., Hatzis, E., Moss, R.M., Parisot, J.P., Yang, H., Czabotar, P.E., Fairlie, W.D., Lee, E.F., Adams, J.M., Chen, L., van Delft, M.F., Lowes, K.N., Wei, A., Huang, D.C., Colman, P.M., Street, I.P., Baell, J.B., Watson, K.G., Lessene, G., 2013, Discovery of potent and selective benzothiazole hydrazone inhibitors of Bcl-XL, Journal of Medicinal Chemistry [P], vol 56, issue 13, American Chemical Society, United States, pp. 5514-5540.

Smeets, M.F.M., Chan, A.C.Y., Dagger, S., Bradley, C., Wei, A., Izon, D.J., 2013, Fli-1 overexpression in hematopoietic progenitors deregulates T cell development and induces pre-T cell lymphoblastic leukaemia/lymphoma, PLoS ONE [P], vol 8, issue 5 (Art. ID: e62346), Public Library of Science, United States, pp. 1-12.

Tan, P., Wei, A., 2013, Limitations of targeted therapy with sorafenib in elderly high-risk myelodysplastic syndrome and acute myeloid leukemia., Leukemia & Lymphoma [P], vol 54, issue 4, Informa Healthcare, London, EC1R 3DA United Kingdom, pp. 675-676.

Thomas, D., Powell, J.A., Green, B.D., Barry, E.F., Ma, Y., Woodcock, J.M., Fitter, S., Zannettino, A., Pitson, S.M., Hughes, T.P., Lopez, A.F., Shepherd, P.R., Wei, A., Ekert, P.G., Guthridge, M.A., 2013, Protein kinase activity of phosphoinositide 3-kinase regulates cytokine-dependent cell survival, PLoS Biology [E], vol 11, issue 3 (Art. No: e1001515), Public Library of Science, United States, pp. 1-14.

Thomas, D., Powell, J.A., Vergez, F., Segal, D., Nguyen, N.N., Baker, A., Teh, T., Barry, E.F., Sarry, J., Lee, E.M., Nero, T.L., Jabbour, A.M., Pomilio, G., Green, B.D., Manenti, S., Glaser, S., Parker, M.W., Lopez, A.F., Ekert, P.G., Lock, R.B., Huang, D.C., Nilsson, S.K., Recher, C., Wei, A., Guthridge, M.A., 2013, Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription, Blood [P], vol 122, issue 5, American Society of Hematology, United States, pp. 738-748.

Tovar-Lopez, F.J., Rosengarten, G., Nasabi, M., Sivan, V., Khoshmanesh, K., Jackson, S., Mitchell, A., Nesbitt, W.S., 2013, An investigation on platelet transport during thrombus formation at micro-scale stenosis, PLoS ONE [P], vol 8, issue 10 (Art. ID: e74123), Public Library of Science, United States, pp. 1-11.

Verstovsek, S., Mesa, R.A., Gotlib, J., Levy, R.S., Gupta, V., DiPersio, J.F., Catalano, J., Deininger, M., Miller, C., Silver, R., Talpaz, M., Winton, E.F., Harvey, J.H., Arcasoy, M.O., Hexner, E., Lyons, R.M., Paquette, R., Raza, A., Vaddi, K., Erickson-Viitanen, S., Sun, W., Sandor, V., Kantarjian, H.M., 2013, Efficacy, safety and survival with ruxolitinib in patients with smyelofibrosis: results of a median 2-year follow-up of COMFORT-I, Haematologica-The Hematology Journal [P], vol 98, issue 12, Fondazione Ferrata Storti, Italy, pp. 1865-1871.

Walker, S., Palma-Dias, R., Wood, E.M., Shekleton, P.A., Giles, M.L., 2013, Cytomegalovirus in pregnancy: to screen or not to screen, BMC Pregnancy and Childbirth [P], vol 13, issue Art. ID: 96, BioMed Central Ltd, United Kingdom, pp. 1-8.

Wei, A., Brown, M., Guthridge, M.A., 2013, The Regulation of Mitochondrial Metabolism by the Bcl-2 Family of Pro-Survival Proteins: New Therapeutic Opportunities for Targeting Cancer Cells, Journal of Hematology & Thromboembolic Diseases [E], vol 1, issue 4, OMICS Publishing Group, Unknown, pp. 1-3.